- This event has passed.
The Future of Low-Cost Blood Lead Level Testing
In July 2026, the Clinton Health Access Initiative (CHAI) and Renaissance Philanthropy published a target product profile (TPP) setting out what a rapid point-of-care blood lead level test would need to do to work at scale. Product developers, diagnostics experts, and public health practitioners are invited to join the initiative by submitting an expression of interest.
This panel discussion will feature users of these tests in clinical and field settings joined by technical experts in lead diagnostics. The panel will talk through where current technologies fall short, what the TPP asks of a new test, and what public health programs could look like if blood lead level tests were easy to use and routine.
It will close with CHAI and Renaissance Philanthropy announcing their launch of a new program to accelerate the development of a new point-of-care blood lead test through financial incentives and technical support.
What attendees will take away:
- How blood lead testing is done today in clinical and field settings, and why it is neither routine nor easy
- What a new test could look like
- How product developers, diagnostics experts, and public health practitioners can take part in this initiative